Financials
- Market Capitalization 20.32 M
- Employee 8
- Founded 1996
- CEO N/A
- Website www.neuphoriatx.com
- Headquarter Australia
- FIGI BBG01RFZ8658
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-30.87
ratio cours/chiffre d'affaires
0.74
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 4549 | COCP Cocrystal Pharma, Inc. - Common Stock | 1.10 USD | -3.51% | -7.56% | +26.44% | -29.03% | 21.19 M USD | ||
| 4557 | AKTX Akari Therapeutics Plc - American Depositary Shares | 10.70 USD | +18.76% | +33.75% | +33.75% | +1289.61% | 20.83 M USD | ||
| 4577 | CMMB Chemomab Therapeutics Ltd - American Depositary Shares | 2.71 USD | -0.37% | +23.74% | +77.12% | +83.73% | 19.49 M USD | ||
| 4593 | PTN Palatin Technologies, Inc. Common Stock | 10.53 USD | +2.63% | +3.85% | +28.73% | +45.24% | 18.74 M USD |